Search clinical trials for: angiotensin receptor neprilysin inhibitor (ARNi)
Total 80288 results
-
Wonju Severance Christian HospitalRecruitingHeart Failure | MortalityKorea, Republic of
-
Brigham and Women's HospitalActive, not recruitingFrailty | Heart Failure, SystolicUnited States
-
Newcastle UniversityUniversity of Belgrade; Azienda Ospedaliero-Universitaria Careggi; University... and other collaboratorsCompletedHypertrophic CardiomyopathyGermany, Italy, Serbia, United Kingdom
-
Dr Khalid AliARNI Institute for Neurological Rehabilitation (ARNI)RecruitingStroke | Rehabilitation | Upper Limb InjuryUnited Kingdom
-
Unity Health TorontoAlere, Inc.Unknown
-
University of LeipzigActive, not recruitingHeart Failure With Reduced Ejection FractionGermany
-
Newcastle-upon-Tyne Hospitals NHS TrustAssistance Publique - Hôpitaux de Paris; Azienda Ospedaliero-Universitaria... and other collaboratorsCompletedHypertrophic CardiomyopathyUnited Kingdom
-
Novartis PharmaceuticalsCompletedEssential HypertensionTaiwan, Japan, Hong Kong, Thailand, Philippines, China, Korea, Republic of
-
RenJi HospitalUnknown
-
Brigham and Women's HospitalNovartis PharmaceuticalsWithdrawnHeart Failure With Reduced Ejection Fraction
-
Universidade do PortoRede de Investigação em Saúde (RISE), Laboratório Associado; Faculty of Medicine... and other collaboratorsRecruitingHeart Failure With Reduced Ejection FractionPortugal
-
First Affiliated Hospital Xi'an Jiaotong UniversityBaoji Central Hospital; First Affiliated Hospital Xi'an Medical UniversityUnknownChronic Heart FailureChina
-
Montreal Heart InstituteNovartis PharmaceuticalsTerminatedHeart Failure | Systemic Right VentricleCanada
-
Hannover Medical SchoolDLR German Aerospace CenterWithdrawn
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisPortugal, Spain, Sweden, Brazil, United States, France, Germany
-
Alnylam PharmaceuticalsCompleted
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisUnited States, United Kingdom
-
National Heart Centre SingaporeNational Medical Research Council (NMRC), SingaporeRecruitingHypertensive Heart DiseaseSingapore
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisPortugal, Sweden, Brazil, United States, France, Spain, Germany
-
Alnylam PharmaceuticalsCompletedA Study of the Safety, Tolerability and Pharmacokinetics of ALN-TTR02 in Japanese Healthy VolunteersTransthyretin (TTR)-Mediated AmyloidosisUnited Kingdom
-
Mohammed AlnimsCompletedHeart Failure With Reduced Ejection FractionEgypt
-
Novartis PharmaceuticalsCompletedHypertensionChina, Taiwan, Japan, Thailand, Korea, Republic of
-
Duke UniversityNovartis PharmaceuticalsCompleted
-
Genzyme, a Sanofi CompanyCompletedHemophilia A | Hemophilia BBulgaria, United States, United Kingdom, Russian Federation, Switzerland
-
Novartis PharmaceuticalsActive, not recruitingHeart Failure | Chagas DiseaseBrazil, Argentina, Mexico, Colombia
-
Mark LedwidgeThe Heartbeat TrustActive, not recruitingHypertension | Atrial Remodeling | Cardiovascular Morbidity | Myocardial Dysfunction | Atrial Arrhythmia | Left Ventricular Remodeling | Left Ventricular Diastolic Dysfunction | Inflammatory Myopathy | Fibrosis MyocardialIreland
-
Novartis PharmaceuticalsCompletedSystolic HypertensionUnited States, Spain, Hungary, Korea, Republic of, Argentina, India, Slovakia, Canada, Romania
-
Novartis PharmaceuticalsCompletedEssential HypertensionChina, Taiwan, Japan, Thailand, Korea, Republic of
-
The Cleveland ClinicRecruitingStage D Heart FailureUnited States
-
Novartis PharmaceuticalsCompletedAcute Myocardial InfarctionChina, United States, South Africa, Italy, Spain, Croatia, Czechia, Hungary, Romania, Taiwan, Belgium, Germany, Netherlands, Austria, Denmark, United Kingdom, Thailand, Argentina, Israel, Australia, Bulgaria, France, Greece, Russian Federation and more
-
Sylentis, S.A.CompletedOcular Hypertension | GlaucomaSpain
-
Alnylam PharmaceuticalsCompletedParoxysmal Nocturnal Hemoglobinuria (PNH)Spain, United Kingdom
-
Alnylam PharmaceuticalsThe Medicines CompanyCompletedHypercholesterolemiaUnited Kingdom
-
Novartis PharmaceuticalsCompletedHeart Failure | Erectile Dysfunction | Heart Failure, SystolicGermany
-
The Cleveland ClinicWithdrawnCardiogenic ShockUnited States
-
West China HospitalNot yet recruiting
-
National Institute of Cardiovascular Diseases,...CompletedHeart Failure, SystolicPakistan
-
Alnylam PharmaceuticalsCompletedAcute Intermittent PorphyriaUnited States, United Kingdom, Sweden
-
Novartis PharmaceuticalsTerminated
-
Novo Nordisk A/SCompletedKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2)Poland, United States, United Kingdom, New Zealand, Australia, Canada, France, Germany, Israel, Italy, Japan, Lebanon, Netherlands, Romania, Spain
-
The Second Affiliated Hospital of Chongqing Medical...UnknownAtrial Fibrillation | Cardiac Remodeling, Atrial | Sacubitril/Valsartan
-
Mayo ClinicRecruitingDiabetes Mellitus, Type 2 | Diastolic DysfunctionUnited States
-
University of Sao Paulo General HospitalInCor Heart InstituteRecruiting
-
Beijing Tsinghua Chang Gung HospitalNot yet recruitingHypertension | Atrial FibrillationChina
-
Alnylam PharmaceuticalsNo longer availableTransthyretin-mediated Amyloidosis With Cardiomyopathy | ATTR Amyloidosis With CardiomyopathyUnited States
-
The Young Investigator Group of Cardiovascular...CompletedAcute Myocardial InfarctionEgypt
-
Nicolai Jacob Wewer AlbrechtsenCompleted
-
Sylentis, S.A.CompletedOcular Hypertension | Open Angle GlaucomaSpain, Germany, United States, Estonia
-
Alnylam PharmaceuticalsActive, not recruitingTransthyretin Amyloidosis (ATTR) With CardiomyopathyUnited States, Australia, Brazil, Bulgaria, France, Italy, Japan, Mexico, Netherlands, Taiwan, United Kingdom, Belgium, Czechia, Denmark, New Zealand, Sweden, Korea, Republic of, Argentina, Chile, Hong Kong, Portugal
-
Alnylam PharmaceuticalsCompletedPrimary Hyperoxaluria Type 1 (PH1)France, United Kingdom, Netherlands, Israel, Germany